Amer Ghavanini

Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology

Health EN ↓ 207 episodes

A selection of recent neurology papers is summarized and discussed, with a focus on review articles and those that have the potential to change clinical practice. Please note that AI has been used in generating the content.

Author

Amer Ghavanini

Category

Health

Podcast website

podcasters.spotify.com

Latest episode

Jul 6, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

A Review of Posterior Reversible Encephalopathy Syndrome (PRES) 26.02.2026

The provided source is a comprehensive  narrative review  of  Posterior Reversible Encephalopathy Syndrome (PRES) , an acute neurological condition defined by  brain edema  and symptoms like  seizures and headaches . It explores the  pathophysiology  of the disease, focusing on how  high blood pressure  and  endothelial injury  disrupt the  blood-brain barrier . The text highlights that while the...

General neurologists guide for diagnosis of atypical parkinsonian disorders 25.02.2026

This consensus statement provides a  practical diagnostic framework  to help general neurologists identify  atypical parkinsonian disorders (APDs) , such as progressive supranuclear palsy and multiple system atrophy. Because these conditions often mimic Parkinson’s disease but progress more rapidly and respond poorly to standard treatments, the authors offer an  iterative algorithm  based on clini...

Refractory, intensive care–dependent NMDAR encephalitis 24.02.2026

This research study establishes a formal definition for  refractory, intensive care–dependent NMDAR encephalitis (RI-NMDARE) , identifying it as cases requiring over  90 days of ICU support  despite second-line immunotherapy. The authors found that approximately  12% of severe patients  fall into this high-risk category, which is characterized by a  rapidly progressing disease  and a higher preval...

LRP4 Antibodies in Suspected Myasthenia Gravis Diagnosis 23.02.2026

This multicenter study investigates the prevalence and diagnostic utility of  LRP4 antibodies  in patients with suspected  myasthenia gravis (MG) . By comparing three different  cell-based assay (CBA)  protocols, researchers found that these antibodies are rare, appearing in only  2% of MG cases  and even in some patients with unrelated neurological disorders. The results were  highly inconsistent...

Autoimmune encephalitis during the COVID-19 pandemic 22.02.2026

This research study examines the  incidence and severity  of  autoantibody-associated autoimmune encephalitis (AE)  during the COVID-19 pandemic compared to a prepandemic period. Using data from  24 medical centers , researchers found that new hospital cases of AE actually  decreased  between 2020 and 2022, particularly those involving  neuronal surface antibodies . The analysis suggests that  SAR...

Dermatomyositis: Modern Diagnostic Paradigms 11.02.2026

This  2025 academic review  provides a comprehensive update on  dermatomyositis (DM) , an inflammatory disease primarily affecting the  skin and skeletal muscles . The authors emphasize that  specific skin lesions , such as Gottron papules and the heliotrope rash, are vital for early diagnosis and can signal serious risks like  malignancy or lung disease . A major focus is placed on  myositis-spec...

The HTLV-1 Neurological Complex: Beyond Myelopathy 10.02.2026

This research article advocates for a  comprehensive shift  in how medical professionals categorize and diagnose the  neurological effects of HTLV-1 . While the virus is traditionally linked to  spinal cord disease , the authors introduce the  HTLV-1 neurological complex  to describe a broader range of symptoms, including  cognitive decline ,  nerve damage , and  muscle inflammation . This "i...

Alpha-Lipoic Acid Efficacy in Managing Diabetic Polyneuropathy Symptoms 09.02.2026

This research article presents a  meta-analysis  and  systematic review  investigating the effectiveness of  alpha-lipoic acid (ALA)  in treating  diabetic peripheral neuropathy . The authors synthesize data from  randomized controlled trials  to determine how this antioxidant affects  nerve damage symptoms , such as  burning and numbness , alongside metabolic markers like  fasting glucose  and  c...

Etiological Screening Strategies for Small Fiber Neuropathy 08.02.2026

This article outlines a systematic approach for clinicians to identify the underlying causes of  small fiber neuropathy (SFN) , a condition where standard tests often fail to provide an etiology. The authors categorize diagnostic investigations into  first-line blood tests , which screen for common metabolic, endocrine, and inflammatory triggers like  diabetes, vitamin deficiencies, and autoimmune...

Tenecteplase in acute central retinal artery occlusion, a phase 3 Clinical Trial 04.02.2026

This  phase 3 clinical trial , known as  TenCRAOS , investigated whether the drug  tenecteplase  could improve vision for patients suffering from  acute central retinal artery occlusion . Researchers compared the efficacy and safety of a  single intravenous injection  of the thrombolytic agent against a standard dose of  oral aspirin  when administered within a tight  4.5-hour window . The study f...

How to use blood-based biomarkers to diagnose Alzheimer’s disease 03.02.2026

This episodes summarizes three papers on significant advancements and clinical recommendations for utilizing  blood-based biomarkers  to diagnose  Alzheimer’s disease  and other neurodegenerative conditions. Research highlights how testing for proteins like  p-tau217 ,  amyloid-beta , and  neurofilament light chain  offers a less invasive, more affordable alternative to traditional spinal taps or...

Brief Review - 2026 Guidelines for Early Management of Acute Ischemic Stroke 01.02.2026

The  2026 American Heart Association and American Stroke Association guidelines  provide a comprehensive framework for the  early management of acute ischemic stroke . Developed by a  multidisciplinary writing group , the document updates clinical protocols for  prehospital coordination ,  emergency evaluation , and  advanced reperfusion therapies . Key recommendations endorse the use of  tenectep...

Multifocal Motor Neuropathy: Clinical Features, Diagnosis, and Treatment Bibliography 25.01.2026

This review explores  multifocal motor neuropathy (MMN) , a rare autoimmune condition characterized by  progressive muscle weakness  and  motor conduction blocks . The paper details how the disease predominantly impacts the  distal upper limbs  of middle-aged men while sparing sensory functions.  Electrodiagnostic testing ,  nerve ultrasound , and  MRI  serve as vital tools for identifying nerve e...

Stiff Person Syndrome: Clinical Spectrum, Diagnosis, and Management 25.01.2026

Stiff-person syndrome (SPS)  is a rare  autoimmune neurological disorder  primarily defined by muscle rigidity and painful spasms caused by impaired inhibitory neurotransmission. This comprehensive review details how the condition often involves  antibodies against glutamic acid decarboxylase (GAD)  and can manifest in various forms, ranging from classical stiffness to complex  spectrum disorders...

Management of Dementia with Lewy Bodies, A Review 25.01.2026

This review article provides a comprehensive guide for  diagnosing and managing dementia with Lewy bodies (DLB) , a condition frequently prone to misidentification. The authors emphasize the importance of recognizing  core clinical features , such as  cognitive fluctuations, visual hallucinations, parkinsonism, and REM sleep behavior disorder . Beyond traditional symptoms, the text highlights  pro...

Seronegative Autoimmune Encephalitis 18.01.2026

This research study presents a  systematic review and meta-analysis  of 224 patients to characterize  seronegative autoimmune encephalitis , a condition where individuals show symptoms of brain inflammation without detectable autoantibodies. The authors identify two primary categories— limbic encephalitis  and  antibody-negative probable autoimmune encephalitis —noting that the latter typically re...

Guidelines for the Diagnosis and Clinical Management of Cavernous Malformations of the Brain and Spinal Cord 18.01.2026

This episode provides  updated clinical guidelines  for the  diagnosis and management  of cavernous malformations (CMs) within the brain and spinal cord. Created by a  multidisciplinary panel of experts , the text synthesizes nearly a decade of recent research to establish  evidence-based recommendations  for medical professionals. Key areas of focus include  genetic testing for familial forms , s...

Distinguishing Vestibular Vertigo from Posterior Stroke 18.01.2026

This review article examines the critical challenge of distinguishing between  benign inner ear issues  and  life-threatening strokes  in patients presenting with  acute vertigo . Because standard  neuroimaging  often fails to detect early-stage strokes, the author advocates for a  structured bedside examination  that prioritizes the identification of  neurological red flags . Key assessment tools...

2025 In Review - MS and Autoimmune CNS Disorders 29.12.2025

This 2025 literature review synthesizes significant  advancements in treating and monitoring multiple sclerosis  and related autoimmune central nervous system disorders. The text highlights  breakthrough clinical trials  for Bruton’s tyrosine kinase inhibitors, such as tolebrutinib and fenebrutinib, which offer new hope for slowing disability in  progressive disease phenotypes . Beyond pharmaceuti...

2025 In Review - Epilepsy 29.12.2025

This episode provides a  comprehensive analysis of epilepsy research  published throughout 2025, detailing major shifts in  clinical diagnostics and treatment . It highlights a significant update by the  International League Against Epilepsy , which simplified seizure classifications to improve global medical communication. The text evaluates the long-term success of  modern medications  like fenf...

2025 In Review - Stroke and Neurovascular Disorders 29.12.2025

This episodes summarizes the  most significant research developments  in stroke and neurovascular medicine throughout the year 2025. It details a shift in acute care where  tenecteplase  has emerged as the favored drug for bridging therapy before clot removal. Conversely, the text highlights that mechanical intervention for  smaller or distant vessel blockages  may not offer benefits over standard...

2025 In Review - Movement Disorders 28.12.2025

This comprehensive review synthesizes  high-impact research  from 2025 regarding  movement disorders , specifically focusing on  Parkinson’s disease  and  hereditary ataxias . The literature highlights critical clinical trial results, such as the failure of  exenatide  as a disease-modifying therapy and the burgeoning potential of  stem cell regenerative medicine . It also identifies significant ...

2025 In Review - Neuromuscular Disorders 28.12.2025

This comprehensive review synthesizes  high-impact research  and clinical developments within the field of  neuromuscular disorders  throughout 2025. The paper details significant breakthroughs in  therapeutic interventions , including novel gene therapies, complement inhibitors, and immune-modulating agents for conditions such as  ALS and Myasthenia Gravis . It highlights updated  clinical guidel...

GLP-1 Receptor Agonists: Efficacy, Safety, and Neurological Frontiers 28.12.2025

These papers provide a comprehensive overview of  GLP-1 and dual GLP-1/GIP receptor agonists , highlighting their transformative role in treating  type 2 diabetes and obesity . The texts detail the  pharmacology and dosing  of specific agents like semaglutide and tirzepatide, comparing their effectiveness in  glycemic control and weight loss . Beyond metabolic health, the research explores  emergi...

Treating psychiatric comorbidities in patients with epilepsy. 21.12.2025

Patients diagnosed with  epilepsy  frequently encounter  psychiatric and behavioral comorbidities , such as anxiety, depression, and ADHD, at rates significantly higher than the general population. This text outlines the  pharmacological management  of these conditions, emphasizing that effective seizure control often depends on addressing a patient's overall  mental health and quality of life...

Listen to the Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.